Sentinel lymph node and clinically negative axillary node status was compared with well-known clinicopathological characteristics such as tumor size, histologic and nuclear grade, lymphovascular invasion, steroid receptor, and HER-2 status in patients with breast cancer (pT1 and pT2). Positive sentinel lymph nodes were found in 29 of 100 patients: 19 with metastases detected by hematoxylin and eosin staining and 10 with micrometastases confirmed by immunohistochemistry with cytokeratin. Positive sentinel lymph nodes were present in larger carcinomas (P < 0.03), more frequently in tumors with negative PR status (P < 0.037) and evident lymphovascular invasion (P < 0.002). Lymphovascular invasion was also associated with breast cancer of higher histologic (P = 0.011) and nuclear grade (P = 0.039). Tumor size and the presence of lymphovascular invasion were found to be significant predictors of pathologically positive sentinel lymph node in T1 and T2.
Dees EC, Shulman LN, Souba WW, et al.Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection. Ann Surg. 1997;226: 279-286.
2.
Dowlatshahi K, Fan M, Snider HC, Habib FA.Lymph node micrometastases from breast carcinoma. Cancer. 1997;80: 1188-1197.
3.
Rampaul R, Miremadi A, Pinder S, et al.Pathological validation of significance of micrometastasis in sentinel nodes in primary breast cancer. Breast Cancer Res. 2001;3: 113-116.
4.
Trocha SD, Giuliano AE.Sentinel node in the era of neoadjuvant therapy and locally advanced breast cancer. Surg Oncol. 2003;12: 271-276.
5.
Dawson PJ, Ferguson DJ, Karrison T.The pathologic findings of breast cancer in patients surviving 25 years after radical mastectomy. Cancer. 1982;50: 2131-2138.
6.
Pinder S, Ellis IO, O’Rourke S, et al.Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large series with long-term follow-up. Histopathology. 1994; 24: 41-47.
Zerwes FP, Frasson AL, Gutfilen B, Barbosa da Fonseca LM.Identification of sentinel node in breast cancer. J Exp Clin Cancer Res. 2002;21: 155-158.
10.
Pargaonkar AS, Beissner RS, Snyder S, Speights VO.Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. Arch Pathol Lab Med. 2003;127: 701-705.
11.
Pelosi E, Arena V, Baudino B, et al.Sentinel node detection in breast carcinoma. Tumori. 2002;88: 110-111.
12.
Turner RR, Chu KU, Qi K, et al.Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer. 2000;89: 574-581.
13.
Harden SP, Neal AJ, Al-Nasiri N, Ashley S, Querci della Rovere G.Predicting axillary lymph node metastases in patients with T1 infiltrative ductal carcinoma of the breast. Breast. 2001;10: 155-159.
14.
Choi SH, Barsky SH, Chang HR.Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer. Breast J. 2003;9: 153-162.
15.
Ying C, Paner GP, Rajan PB.Sentinel node status and tumor characteristics. Arch Pathol Lab Med. 2005;129: 82-84.
16.
Viale G, Zurrida S, Maiorono E, et al.Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer. 2005;103: 492-500.
17.
D’Errico A, Grassigli A, Gruppioni E, et al.Thorough intraoperative analysis of breast sentinel lymph node biopsies: histologic and immunohistochemical findings. Surgery. 2004;135: 248-254.
18.
Elston CW, Ellis IO, eds. The Breast. 3rd ed.New York, NY: Churchill Livingstone; 1998.
19.
Rosen PP.Rosen’s Breast Pathology. 2nd ed.Baltimore, Md: Lippincott Williams & Wilkins; 2001.
20.
Carter BA, Page DL.Sentinel lymph node histopathology in breast cancer: minimal disease versus artifact. J Clin Oncol. 2006;24: 1978-1979.
21.
Bleiweiss I, Nagi C, Jaffer S.Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol. 2006;24: 2013-2018.
22.
Van Zee KJ, Manasseh DME, Bevilacqua JLB, et al.A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003;10: 1140-1151.
23.
Weiser MR, Montgomery LL, Susnik B, et al.Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile?Ann Surg Oncol. 2000;7: 651-655.
24.
Shiver SA, Creager AJ, Geisinger K, Perrier ND, Shen P, Levine EA.Intraoperative analysis of sentinel lymph nodes by imprint cytology for cancer of the breast. Am J Surg. 2002;184: 424-427.
25.
Suer T, Engh V, Holck AM, et al.Imprint cytology of sentinel lymph nodes in breast cancer. Experience with rapid, intraoperative diagnosis and primary screening by cytotechnologists. Acta Cytol. 2003;47: 768-773.
26.
Creager AJ, Geisniger KR, Perrier ND, et al.Intraoperative imprint cytologic evaluation of sentinel lymph node for lobular carcinoma of the breast. Ann Surg. 2004; 239: 61-66.
27.
Menes TS, Tartter PI, Mizrachi H, Smith SR, Estabrook A.Touch preparation or frozen section for intraoperative detection of sentinel lymph node metastases from breast cancer. Ann Surg Oncol. 2003;10: 1166-1170.
28.
Dowlatshani K, Fan M, Snider HC, Habib FA.Lymph node micrometastases from breast carcinoma. Cancer. 1997;80: 1188-1197.
29.
Cohen C, Alazraki N, Styblo T, Waldrop SM, Grant SF, Larsen T.Immunohistochemical evaluation of sentinel lymph nodes in breast carcinoma patients. Appl Immunohistochem Mol Morphol. 2002;10: 296-303.
30.
Inokuchi M, Ninomiya I, Tsugawa K, Terada I, Miwa K.Quantitative evaluation of metastases in axillary lymph nodes of breast cancer. Br J Cancer. 2003; 89: 1750-1756.
31.
Schroder CP, Ruiters MH, de Jong S, et al.Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes. Int J Cancer. 2003;10: 611-618.
32.
Stitzenberg KB, Calvo BF, Iacocca MV, et al.Cytokeratin immunohistochemical validation of the sentinel node hypothesis in patients with breast cancer. Am J Clin Pathol. 2002;117: 729-737.
33.
Imoto S, Wada N, Murakami K, Hasebe T, Ochiai A, Ebihara S.Prognosis of breast cancer patients treated with sentinel node biopsy in Japan. Jpn J Clin Oncol. 2004;34: 452-456.
